Physician profile
Michael J Driscoll
NPI 1497946792
$9,574.62
in general payments reported to CMS, 2019-2025
46 companies · $2,173 in 2025
The $2,173 reported for 2025 was more than what 77% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,219 · 2020: $494 · 2021: $913 · 2022: $1,886 · 2023: $1,180 · 2024: $1,709 · 2025: $2,173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,976 · Education: $85.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,976.25 |
| Education | $85.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,067.08 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,506.36 | 2019-2025 | Fasenra, Breztri, Airsupra |
| Regeneron Healthcare Solutions, INC. | $535.73 | 2019-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $507.69 | 2019-2025 | |
| Genzyme Corporation | $461.80 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $436.83 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Mylan Specialty L.P. | $436.00 | 2019-2024 | Yupelri |
| Philips North America LLC | $338.27 | 2019-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Harmony Biosciences LLC | $330.54 | 2020-2025 | Wakix |
| Biomerieux INC | $277.43 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $244.58 | 2019-2024 | Opsumit, Uptravi |
| Inari Medical, INC. | $234.51 | 2021-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Novartis Pharmaceuticals Corporation | $211.69 | 2019-2022 | |
| United Therapeutics Corporation | $157.49 | 2019-2022 | |
| Abbott Laboratories | $156.96 | 2019-2021 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $147.18 | 2022-2025 | |
| Genentech USA, INC. | $130.59 | 2019-2025 | Xolair |
| Ani Pharmaceuticals, INC. | $115.93 | 2024-2025 | Purified Cortrophin Gel |
| Takeda Pharmaceuticals U.S.A., INC. | $112.91 | 2022-2025 | Aralast |
| Verona Pharma, INC. | $110.28 | 2025 | Ohtuvayre |
| Amgen INC. | $105.59 | 2022-2025 | Tezspire |
| Merck Sharp & Dohme LLC | $104.16 | 2022-2023 | Belsomra |
| Grifols USA, LLC | $93.63 | 2019-2025 | Prolastin-C Liquid |
| Axsome Therapeutics, INC. | $80.30 | 2023-2025 | Sunosi |
| Insmed, INC. | $78.61 | 2019-2025 | Arikayce |
| Avadel Cns Pharmaceuticals, LLC | $69.87 | 2024-2025 | Lumryz |
| Inspire Medical Systems, INC. | $61.00 | 2024 | Inspire |
| Lilly USA, LLC | $47.52 | 2025 | Zepbound |
| Allergan, INC. | $40.00 | 2019-2020 | |
| Advanced Respiratory, INC | $37.59 | 2019-2020 | |
| Viatris Specialty LLC | $36.52 | 2025 | Yupelri |
| Resmed Corp | $34.80 | 2021-2025 | |
| 3b Medical, INC. | $31.07 | 2025 | Luna |
| Ambu INC. | $30.76 | 2020 | |
| Electromed, INC. | $28.60 | 2019-2024 | Smartvest |
| Sunovion Pharmaceuticals INC. | $22.27 | 2019 | |
| Abbvie INC. | $18.06 | 2025 | |
| Idorsia Pharmaceuticals US INC | $17.31 | 2023 | Quviviq |
| Bayer Healthcare Pharmaceuticals INC. | $17.00 | 2024 | |
| Mallinckrodt Hospital Products INC. | $16.45 | 2022 | |
| Azurity Pharmaceuticals, INC. | $15.89 | 2024 | Horizant |
| E.R. Squibb & Sons, L.L.C. | $14.52 | 2020 | |
| Mallinckrodt Enterprises LLC | $14.02 | 2019 | |
| Pulmonx Corporation | $13.74 | 2023 | Zephyr Endobronchial Valve, Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter |
| Teva Pharmaceuticals USA, INC. | $13.63 | 2022 | |
| Shire North American Group INC | $11.86 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Driscoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.